Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous Thromboembolism

• Autores: Nikolai Madrid Schelle, Björn Pasternak
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 312, Nº. 2, 2014, págs. 187-188
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • A potential association between quadrivalent human papillomavirus (HPV) vaccination and venous thromboembolism (VTE) has been reported in 2 postlicensure safety studies.1,2 An analysis of the Vaccine Adverse Event Reporting System database found disproportionately high reporting of VTE following vaccination,1 and a study using the Vaccine Safety Datalink reported a doubling of VTE risk.2